FRA:JNJ - Deutsche Boerse Ag - US4781601046 - Common Stock - Currency: EUR
Overall JNJ gets a fundamental rating of 5 out of 10. We evaluated JNJ against 52 industry peers in the Pharmaceuticals industry. JNJ has an average financial health and profitability rating. JNJ is not valued too expensively and it also shows a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 11.26% | ||
ROE | 27.92% | ||
ROIC | 13.67% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 26.16% | ||
PM (TTM) | 24.41% | ||
GM | 68.34% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.63 | ||
Debt/FCF | 2.57 | ||
Altman-Z | 4.07 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.26 | ||
Quick Ratio | 1.03 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 15.54 | ||
Fwd PE | 13.91 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 18.45 | ||
EV/EBITDA | 11.79 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 3.33% |
FRA:JNJ (7/7/2025, 7:00:00 PM)
132.72
+0.24 (+0.18%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 3.33% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 15.54 | ||
Fwd PE | 13.91 | ||
P/S | 4.21 | ||
P/FCF | 18.45 | ||
P/OCF | 15.16 | ||
P/B | 4.81 | ||
P/tB | N/A | ||
EV/EBITDA | 11.79 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 11.26% | ||
ROE | 27.92% | ||
ROCE | 17.09% | ||
ROIC | 13.67% | ||
ROICexc | 18.54% | ||
ROICexgc | 72.98% | ||
OM | 26.16% | ||
PM (TTM) | 24.41% | ||
GM | 68.34% | ||
FCFM | 22.8% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.63 | ||
Debt/FCF | 2.57 | ||
Debt/EBITDA | 1.61 | ||
Cap/Depr | 60.47% | ||
Cap/Sales | 4.94% | ||
Interest Coverage | 250 | ||
Cash Conversion | 80.81% | ||
Profit Quality | 93.4% | ||
Current Ratio | 1.26 | ||
Quick Ratio | 1.03 | ||
Altman-Z | 4.07 |